JPWO2023062559A5 - - Google Patents
Info
- Publication number
- JPWO2023062559A5 JPWO2023062559A5 JP2024522260A JP2024522260A JPWO2023062559A5 JP WO2023062559 A5 JPWO2023062559 A5 JP WO2023062559A5 JP 2024522260 A JP2024522260 A JP 2024522260A JP 2024522260 A JP2024522260 A JP 2024522260A JP WO2023062559 A5 JPWO2023062559 A5 JP WO2023062559A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- formula
- compound
- weight
- hiv infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163255056P | 2021-10-13 | 2021-10-13 | |
| US63/255,056 | 2021-10-13 | ||
| US202163257212P | 2021-10-19 | 2021-10-19 | |
| US63/257,212 | 2021-10-19 | ||
| PCT/IB2022/059780 WO2023062559A1 (en) | 2021-10-13 | 2022-10-12 | Inhibitors of human immunodeficiency virus replication |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024535596A JP2024535596A (ja) | 2024-09-30 |
| JP2024535596A5 JP2024535596A5 (https=) | 2025-10-17 |
| JPWO2023062559A5 true JPWO2023062559A5 (https=) | 2025-10-17 |
Family
ID=84044276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522260A Pending JP2024535596A (ja) | 2021-10-13 | 2022-10-12 | ヒト免疫不全ウイルス複製の阻害薬 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240423985A1 (https=) |
| EP (1) | EP4415685A1 (https=) |
| JP (1) | JP2024535596A (https=) |
| KR (1) | KR20240074850A (https=) |
| AU (1) | AU2022362855B2 (https=) |
| CA (1) | CA3234219A1 (https=) |
| CL (1) | CL2024001073A1 (https=) |
| IL (1) | IL311982A (https=) |
| MX (1) | MX2024004551A (https=) |
| WO (1) | WO2023062559A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202128648A (zh) * | 2019-10-04 | 2021-08-01 | 英商Ｖｉｉｖ醫療保健英國(Ｎｏ 5)有限公司 | 人類免疫不全病毒複製之抑制劑 |
| US12594276B2 (en) | 2024-02-05 | 2026-04-07 | Viiv Healthcare Uk (No. 5) Limited | Inhibitors of human immunodeficiency virus replication |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230011471A (ko) * | 2016-08-19 | 2023-01-20 | 길리애드 사이언시즈, 인코포레이티드 | Hiv 바이러스 감염의 예방적 또는 치유적 치료에 유용한 치료 화합물 |
| TWI687415B (zh) * | 2017-08-17 | 2020-03-11 | 美商基利科學股份有限公司 | Hiv蛋白質膜抑制劑之固體形式 |
| CN120053445A (zh) * | 2018-07-16 | 2025-05-30 | 吉利德科学公司 | 用于治疗hiv的衣壳抑制剂 |
| MX2021004593A (es) * | 2018-10-24 | 2021-06-15 | Viiv Healthcare Uk No 5 Ltd | Inhibidores de la replicacion del virus de la inmunodeficiencia humana. |
| LT3986561T (lt) * | 2019-06-19 | 2024-04-25 | VIIV Healthcare UK (No.5) Limited | Pirido[2,3-d]pirimidino dariniai kaip žmogaus imunodeficito viruso replikacijos inhibitoriai |
| CN115397424A (zh) * | 2020-04-15 | 2022-11-25 | Viiv保健英国第五有限公司 | 人类免疫缺陷病毒复制的抑制剂 |
-
2022
- 2022-10-12 US US18/700,402 patent/US20240423985A1/en active Pending
- 2022-10-12 EP EP22797493.8A patent/EP4415685A1/en active Pending
- 2022-10-12 CA CA3234219A patent/CA3234219A1/en active Pending
- 2022-10-12 AU AU2022362855A patent/AU2022362855B2/en active Active
- 2022-10-12 JP JP2024522260A patent/JP2024535596A/ja active Pending
- 2022-10-12 MX MX2024004551A patent/MX2024004551A/es unknown
- 2022-10-12 IL IL311982A patent/IL311982A/en unknown
- 2022-10-12 KR KR1020247014899A patent/KR20240074850A/ko active Pending
- 2022-10-12 WO PCT/IB2022/059780 patent/WO2023062559A1/en not_active Ceased
-
2024
- 2024-04-11 CL CL2024001073A patent/CL2024001073A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0893998B2 (en) | Colonic delivery of nicotine to treat inflammatory bowel disease | |
| US6166044A (en) | Colonic delivery of nicotine to treat inflammatory bowel disease | |
| JP2023002662A5 (https=) | ||
| EP3269372B1 (en) | Topical therapeutic formulations | |
| JP6837486B2 (ja) | 加齢に関連する認知障害及び神経炎症を予防及び／又は治療する方法 | |
| JPS6323964B2 (https=) | ||
| EP3528828B1 (en) | Terlipressin composition for use in treating ascites | |
| CN1422142A (zh) | 药用组合物 | |
| CN1917883A (zh) | 曲前列环素改善肾功能的用途 | |
| JP2024170583A5 (https=) | ||
| KR20120138229A (ko) | 정맥내 투여용 이부프로펜을 이용한 중증 환자의 치료 | |
| WO2019161761A1 (zh) | 一种治疗疟疾的药物组合物 | |
| JPWO2023062559A5 (https=) | ||
| US20050239889A1 (en) | In vivo release of endogenous anti-microbial mediators by leukotriene B4 (LTB4) administration | |
| JP2013510838A (ja) | 微生物感染症の治療 | |
| JP2019515927A (ja) | 感染症の処置のための方法 | |
| RU2024112404A (ru) | Ингибиторы репликации вируса иммунодефицита человека | |
| US20230149352A1 (en) | Uses of apremilast | |
| JPWO2020234781A5 (https=) | ||
| CA2364606A1 (en) | Oil-in-water emulsion for the use as medicament or for producing a medicament | |
| JPWO2020234782A5 (https=) | ||
| JPWO2020222108A5 (https=) | ||
| CN121003688A (zh) | 一种dsRNA与干扰素的联合治疗 | |
| JPWO2021070054A5 (https=) | ||
| WO2023245470A1 (zh) | Mdp类似物在制备用于治疗炎症性肠病的药物中的用途 |